Standardized Care Management Ensures Similar Survival Rates in HIV-Positive and HIV-Negative Patients With Hepatocellular Carcinoma
- 15 December 2012
- journal article
- research article
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 61 (5) , 581-587
Abstract
Objective: It has been suggested that HIV infection has a detrimental impact on patients with hepatocellular carcinoma (HCC). The present study sought to test this hypothesis, while controlling for tumor extension and liver disease. Design and Setting: A case control and a cohort approach were performed in patients with HCC managed prospectively via dedicated multidisciplinary team meeting in a single tertiary institution between 2004 and 2009. Subjects: Of 473 consecutive treatment-naive patients with HCC, 23 were HIV-positive (HIV+) and 450 were HIV-negative (HIV−). HIV+ patients were matched 1:2 with a control group of HIV− patients in terms of the etiology of HCC, the severity of liver disease, tumor extension, and year of diagnosis. Intervention: Curative or palliative treatment of HCC. Main Outcome Measures: Eligibility for HCC treatment, the treatment actually administered, and the survival rate. Results: The HIV+ population was younger than the HIV− population (mean age: 49 vs. 61 years, respectively; P < 0.0001). Curative treatment was recommended by the multidisciplinary team meeting and then actually performed to a similar extent in HIV+ patients (74% and 43%, respectively) and their matched HIV− controls (74% and 56%, respectively). The HIV+ and their matched HIV− patients did not differ significantly in terms of the 3-year survival rate [44% vs. 48%, respectively; mean (95% confidence interval) hazard ratio = 0.64 (0.3–1.3); P = 0.2]. In a cohort analysis, HIV status was not an independent predictor of survival among curatively treated patients. Conclusion: In an equal-access unbiased environment, HIV status does not significantly influence treatment access, delivery, and outcome.Keywords
This publication has 27 references indexed in Scilit:
- Increasing burden of liver disease in patients with HIV infectionThe Lancet, 2011
- Cancer as a Cause of Death among People with AIDS in the United StatesClinical Infectious Diseases, 2010
- Emerging role of hepatocellular carcinoma among liver-related causes of deaths in HIV-infected patients: The French national Mortalité 2005 studyJournal of Hepatology, 2009
- Hepatocellular carcinoma in HIV-infected patients comes of age: The convergence of epidemiology and treatment effectivenessJournal of Hepatology, 2009
- Changes in the Risk of Death After HIV Seroconversion Compared With Mortality in the General PopulationJAMA, 2008
- Liver-Related Deaths in Persons Infected With the Human Immunodeficiency VirusArchives of internal medicine (1960), 2006
- Liver‐related mortality in human‐immunodeficiency‐virus‐infected patients between 1995 and 2003 in the French GERMIVIC Joint Study Group Network (MORTAVIC 2003 Study)*Journal of Viral Hepatitis, 2006
- Liver disease as a major cause of death among HIV infected patients: role of hepatitis C and B viruses and alcoholJournal of Hepatology, 2005
- Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver DiseaseNew England Journal of Medicine, 2004
- Hepatotoxicity Associated With Antiretroviral Therapy in Adults Infected With Human Immunodeficiency Virus and the Role of Hepatitis C or B Virus InfectionJAMA, 2000